Fei Bai
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Cancer-related molecular mechanisms research 3
- Co-authors
- Di Xue (6 shared papers)Yingbin Hu (2 shared papers)Jingshi Liu (1 shared paper)Jiarui Jiang (1 shared paper)Ping Zhou (1 shared paper)Zhang Yu (1 shared paper)Sheng Wang (1 shared paper)Jianwei Shi (1 shared paper)
- Journals
- Frontiers in Oncology (3 papers)Radiation Oncology (2 papers)BMJ Open (2 papers)BioScience Trends (2 papers)PLoS ONE (2 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Fei Bai
41 papers receiving 451 citations
Peers
Comparison fields: 5 of 85
- Health Informatics 9
- Cancer Research 64
- Obstetrics and Gynecology 24
- Immunology and Allergy 19
- Pharmacy 13
Countries citing papers authored by Fei Bai
This map shows the geographic impact of Fei Bai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Bai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Bai more than expected).
Fields of papers citing papers by Fei Bai
This network shows the impact of papers produced by Fei Bai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Bai. The network helps show where Fei Bai may publish in the future.
Co-authors
The 25 scholars most cited alongside Fei Bai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 69 | |
| 2 | 2015 | 65 | |
| 3 | 2018 | 29 | |
| 4 | 2021 | 27 | |
| 5 | 2013 | 26 | |
| 6 | 2018 | 23 | |
| 7 | 2021 | 21 | |
| 8 | 2022 | 17 | |
| 9 | 2018 | 17 | |
| 10 | 2018 | 15 | |
| 11 | 2018 | 13 | |
| 12 | 2018 | 12 | |
| 13 | 2018 | 12 | |
| 14 | 2021 | 11 | |
| 15 | 2019 | 10 | |
| 16 | 2021 | 9 | |
| 17 | 2022 | 8 | |
| 18 | 2022 | 8 | |
| 19 | 2022 | 6 | |
| 20 | 2022 | 6 |
About Fei Bai
Fei Bai is a scholar working on Molecular Biology, Cancer Research, Surgery, Pulmonary and Respiratory Medicine and Public Health, Environmental and Occupational Health, having authored 44 papers that have together received 453 indexed citations. Recurring topics across this work include Pain Mechanisms and Treatments (3 papers), Clinical practice guidelines implementation (3 papers), Cancer-related molecular mechanisms research (3 papers), Advanced Radiotherapy Techniques (3 papers), Neuropeptides and Animal Physiology (3 papers), Management of metastatic bone disease (2 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers) and Gastric Cancer Management and Outcomes (2 papers). The work is most often cited by research in Health Informatics (9 citations), Cancer Research (64 citations), Obstetrics and Gynecology (24 citations), Immunology and Allergy (19 citations) and Pharmacy (13 citations). Fei Bai has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Di Xue, Yingbin Hu, Jingshi Liu, Jiarui Jiang, Ping Zhou, Zhang Yu, Sheng Wang, Jianwei Shi, Xinkai Zhang and Leiyu Shi. Their work appears in journals such as Frontiers in Oncology, Radiation Oncology, BMJ Open, BioScience Trends and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.